Lakewood Amedex Biotherapeutics Inc (LABT)

Finanzdaten der Lakewood Amedex Biotherapeutics Inc-Aktie (LABT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate
	327.37%3.79	0.89
Research and Development	176.16%0.50	0.18
Operating Income/Loss	327.37%-3.79	-0.89
Nonoperating Income/Loss	148.31%0.02	-0.04
	308.54%-3.77	-0.92
Attributable To Parent	308.54%-3.77	-0.92
Available To Common Stockholders, Basic	175.19%3.90	1.42
Basic Average Shares	79.70%1.42	7.00
Diluted Average Shares	79.70%1.42	7.00
Basic Earnings Per Share	1,275%-2.75	-0.20
Diluted Earnings Per Share	1,275%-2.75	-0.20